+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Vinorelbine (NVB) oral (NVBo) in combination with carboplatin (CBDCA) followed by maintenance therapy with single agent vinorelbine oral in stage III/IV non-small cell lung cancer (NSCLC): Final results of a multicenter international phase II trial

, : Vinorelbine (NVB) oral (NVBo) in combination with carboplatin (CBDCA) followed by maintenance therapy with single agent vinorelbine oral in stage III/IV non-small cell lung cancer (NSCLC): Final results of a multicenter international phase II trial. Journal of Clinical Oncology 24(18_suppl): 7126-7126

NlmCategory="UNASSIGNED">7126 Background: NVB i.v. day 1 (25 mg/ m2) & NVBo day 8 (60 mg/ m2) and CBDCA AUC 5 have been previously studied in chemonaive NSCLC patients (pts) (O'Brien et al, Ann Oncol 2004; 15: 921). We investigated the efficacy and safety of NVBo weekly with CBDCA AUC 5 q3w for 4 cycles(Cy) followed by maintenance therapy with single agent NVBo in non progressive pts. Inoperable NSCLC stage IIIB, stage IV or delayed relapse of any stage becoming unresectable, KPS ≥ 80%, treated with combination therapy every 3 weeks for 4 Cy: NVBo 60 mg/m2 on days 1, 8 and 15 (Cy1), 80 mg/m2 (Cy2-4) in absence of neutropenia NCI CTC V2 G3/4; CBDCA AUC 5 day 1, administered over 1 hour. Maintenance therapy if pts did not have a PD: NVBo 60 mg/m2 for the first three weekly administrations, followed by NVBo at 80 mg/m2/week until PD. from December 2003 to January 2005 57/56 pts have been registered/treated: median age 61 yrs (37-71); median KPS 90%; male 71.4%; Squamous cell 30%, Adenocarcinoma 50%; Stage III/IV 32.1/62.5% ; median dose intensity NVBo (% RDI) : combination, 50.1 mg/m2/w (67.3%), maintenance 56.2 mg/m2/w (70.2%); pts with NVBo dose escalation from 60 to 80 mg/m2 during combination : 36/52 (69.2%). Tolerance (% of pts with G3/4 NCI CTC V2) : Neutropenia 23.2/44.6; Platelets 16.1/1.8; Hb 19.6/3.6; Nausea 7.1/0; Vomiting 7.1/0; Diarrhea 5.4/0. No G3/4 toxicity was reported for Infection, Bilirubin, Creatinine, Stomatitis, and motor/sensory Neuropathy. Febrile Neutropenia was reported in 5 patients (8.9%). (RECIST) Percent Overall Response rates (n =56 pts) PR 17.9, SD 53.6, PD 23.2, NE 5.4; Progression-Free Survival 4.3 (95% CI [3.1-5.1]) months; Overall Survival 9.7 (95% CI [7.7-11.9]) months. NVBo on a weekly schedule and CBDCA AUC5 in combination therapy for 4 Cy followed by NVBo in maintenance therapy is an effective and safe treatment regimen for advanced NSCLC. The avoidance of further CBDCA administrations after 4 Cy and the use of NVBo as a maintenance therapy until PD has promise as an alternative to the 6 Cy option and calls for further comparative studies. [Table: see text].


PMID: 27953815

Other references

Alcala, R.; Ceballos, R.; D.L.B.Rreda, P.; Ortega, R.; Rios, V., 1956: On a case of craniosynostosis. Revista Clinica Espanola 61(6): 389-392

Chierici, F.; Zenari, G.; Orlandi, F., 1965: On unstable bundle branch blocks. Clinico-electrocardiographic contribution. Cardiologia Pratica 16(6): 662-692

Hollon, T., 2000: HGS targets patent-expiring drugs. Nature Biotechnology 18(12): 1238-1239

Chiarugi, V.; Magnelli, L.; Cinelli, M.; Turchetti, A.; Ruggiero, M., 1995: Dominant oncogenes, tumor suppressors, and radiosensitivity. A variety of conflicting results appeared in the literature concerning the effect of dominant oncogenes on the sensitivity to irradiation and to anticancer agents in a number of cell lines of human and animal origin. In this report we provide evid...

Schang, J.C.; Dauchel, J.; Marescaux, J.; Mougin, C.; Angel, F.; Grenier, J.F., 1978: Role of the ileum in the motor adaptive changes after jejuno-ileal shunt. Electromyographic study. Gastroenterologie Clinique et Biologique 2(4): 373-382

Weiss, Y.G.; Bromberg, Z.; Raj, N.; Raphael, J.; Goloubinoff, P.; Ben-Neriah, Y.; Deutschman, C.S., 2007: Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome. Acute respiratory distress syndrome is a common and highly lethal inflammatory lung syndrome. We previously have shown that an adenoviral vector expressing the heat shock protein (Hsp)70 (AdHSP) protects against experimental sepsis-induced acute r...

Shattil, S.; Leong, L.; Abrams, C.; Cunningham, M.; Parsons, T.; O'toole, T.; Ginsberg, M., 1994: The sequences of the cytoplasmic tails of integrin alpha-IIb-beta-3 influence tyrosine phosphorylation of the focal adhesion kinase pp125-FAK. Circulation 90(4 PART 2): I86

Nimmannitya, S.; Hutamai, S.; Kalayanarooj, S.; Rojanasuphot, S., 1995: A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines. A field study to compare the immune response of children aged 1-6 years to Nakayama and Beijing strains JE vaccines was carried out in Mae Hong Son Province, northwest Thailand, where there was low incidence of JEV infection. The first and second...

Sacchettoni, S.A., 2004: Infected CNS infusion pumps. Is there a chance for treatment without removal?. Acta Neurochirurgica 146(12): 1389-1389

Jedrzejewska E.A., 1985: Ultrastructural changes of adrenal zona glomerulosa and zona fasciculata following long term administration of ethanol in the rat. Examinations were carried out on 5-8 mo. old male white rats. Ethanol was administered through a stomach probe every day in the dose being half lethal dose for a male white rat. The study showed increasing changes in the ultrastructure of supraren...